{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:50:44Z","timestamp":1747165844071,"version":"3.40.5"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jpba.2015.01.034","type":"journal-article","created":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T14:45:44Z","timestamp":1422197144000},"page":"432-436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Determining trace amounts and the origin of formaldehyde impurity in Neisseria meningitidis A\/C\/Y\/W-135-DT conjugate vaccine formulated in isotonic aqueous 1\u00d7 PBS by improved C18-UPLC method"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9549-803X","authenticated-orcid":false,"given":"Seshu K.","family":"Gudlavalleti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika N.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhi N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana J.","family":"Orten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery D.","family":"Harder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeri R.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"Formaldehyde. http:\/\/whqlibdoc.who.int\/hq\/2002\/a73769.pdf. 2nd January 2015.","key":"10.1016\/j.jpba.2015.01.034_bib0075"},{"key":"10.1016\/j.jpba.2015.01.034_bib0080","first-page":"1","article-title":"Sur la toxine et sur l\u2019 anatoxine diphtheriques","volume":"38","author":"Ramon","year":"1924","journal-title":"Ann. Inst. Pasteur."},{"key":"10.1016\/j.jpba.2015.01.034_bib0085","first-page":"283","article-title":"Diphtheria toxoid as an immunizing agent","volume":"4","author":"Glenny","year":"1923","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.jpba.2015.01.034_bib0090","first-page":"979","article-title":"Inactivation of poliovirus by formaldehyde: theoretical and practical aspects","volume":"17","author":"Gard","year":"1957","journal-title":"Bull. World. Health Organ."},{"issue":"12","key":"10.1016\/j.jpba.2015.01.034_bib0095","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/IAI.63.12.4619-4627.1995","article-title":"Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters","volume":"63","author":"Torres","year":"1995","journal-title":"Infect. Immun."},{"unstructured":"http:\/\/www.chop.edu\/service\/vaccine-education-center\/vaccine-safety\/vaccine-ingredients\/formaldehyde.html. 2nd January 2015.","key":"10.1016\/j.jpba.2015.01.034_bib0100"},{"unstructured":"http:\/\/www.gpo.gov\/fdsys\/pkg\/CFR-2012-title9-vol1\/pdf\/CFR-2012-title9-vol1-sec113-205.pdf. 2nd January 2015.","key":"10.1016\/j.jpba.2015.01.034_bib0105"},{"key":"10.1016\/j.jpba.2015.01.034_bib0110","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.vaccine.2013.03.071","article-title":"Pharmacokinetic modeling as an approach to assessing the safety of residual formaldehyde in infant vaccines","volume":"31","author":"Mitkus","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jpba.2015.01.034_bib0115","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"46","key":"10.1016\/j.jpba.2015.01.034_bib0120","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1016\/j.vaccine.2009.06.013","article-title":"Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challenges","volume":"27","author":"Frasch","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jpba.2015.01.034_bib0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/chromsci\/46.6.461","article-title":"HPLC-UV method development and validation for the determination of low level formaldehyde in a drug substance","volume":"46","author":"Soman","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2015.01.034_bib0130","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac5003933","article-title":"Quantification of each serogroup polysaccharide of Neisseria meningitidis in A\/C\/Y\/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis","volume":"86","author":"Gudlavalleti","year":"2014","journal-title":"Anal. Chem."},{"unstructured":"http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm073384.pdf. 2nd January 2015.","key":"10.1016\/j.jpba.2015.01.034_bib0135"},{"unstructured":"http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm265700.htm. 2nd January 2015.","key":"10.1016\/j.jpba.2015.01.034_bib0140"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708515000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T09:46:02Z","timestamp":1598694362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708515000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":14,"alternative-id":["S0731708515000448"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.034","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determining trace amounts and the origin of formaldehyde impurity in Neisseria meningitidis A\/C\/Y\/W-135-DT conjugate vaccine formulated in isotonic aqueous 1\u00d7 PBS by improved C18-UPLC method","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2015.01.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}